Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
Roswell Park Cancer Institute
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
Mayo Clinic
University of Rochester
Mayo Clinic